Funding for this research was provided by:
Clinical Innovation Center (Clinical Innovation Center Accelerator Award)
Prostate Cancer Foundation
Received: 20 March 2019
Accepted: 15 October 2019
First Online: 7 November 2019
Ethics approval and consent to participate
: Ethics committee approval for this study has been obtained through the University of California, San Francisco Institutional Review Board.
: Written consent to participate in any aspect of this pilot study will be obtained from each subject using an information and consent form specific to the nature of participation in this study and in accordance with consent guidelines defined by UCSF IRB.
: The authors declare that they have no competing interests.